Skip to content

Alliance of Infinity Trade

Rabeprazole sodium

Introducing AIT Pharmaceuticals Division’s Rabeprazole Sodium Tablets

At AIT Pharmaceuticals Division, we are dedicated to advancing healthcare by providing high-quality pharmaceutical solutions. Our Rabeprazole Sodium Tablets exemplify our commitment to delivering effective treatments for gastrointestinal disorders. Rabeprazole sodium, the active ingredient in our tablets, is a proton pump inhibitor (PPI) renowned for its potent acid-suppressing properties.

Share

Drug Classification: Rabeprazole sodium belongs to the class of proton pump inhibitors (PPIs), which work by irreversibly inhibiting the hydrogen-potassium adenosine triphosphatase enzyme system in the gastric parietal cells, thereby reducing gastric acid secretion.

Formulation:

  • Rabeprazole Sodium Tablets: Each tablet contains 40mg of rabeprazole sodium, ensuring optimal dosing for patients with acid-related disorders.

Indications:

Rabeprazole sodium tablets are indicated for the:

  • Treatment of gastroesophageal reflux disease (GERD), including erosive esophagitis.
  • Maintenance of healing of erosive esophagitis.
  • Treatment of duodenal ulcers and gastric ulcers.
  • Reduction of risk of gastric ulcers associated with nonsteroidal anti-inflammatory drugs (NSAIDs) in patients at risk.

Pharmacokinetics:

  • Absorption: Rabeprazole sodium is rapidly absorbed after oral administration, with peak plasma concentrations achieved within 1-2 hours.
  • Distribution: It is extensively distributed throughout the body, including the gastrointestinal tract.
  • Metabolism: Rabeprazole sodium undergoes hepatic metabolism via the cytochrome P450 enzyme system, primarily by CYP2C19 and CYP3A4.
  • Elimination: The elimination half-life of rabeprazole sodium is approximately 1-2 hours, with the majority of the drug excreted in the urine as metabolites.

Pharmacodynamics:

Rabeprazole sodium inhibits the proton pump in the gastric parietal cells, resulting in a profound and prolonged suppression of gastric acid secretion. This mechanism of action provides effective relief from symptoms of acid-related disorders and promotes healing of damaged mucosa.

Usage:

  • Rabeprazole sodium tablets should be taken orally, usually once daily, with or without food.

Dosage:

  • The recommended dosage of rabeprazole sodium for adults varies depending on the indication and severity of the condition.
  • For the treatment of GERD and maintenance of healing of erosive esophagitis, the usual dose is 20mg or 40mg once daily for up to 8 weeks.

Side Effects:

  • Common side effects of rabeprazole sodium may include:
    • Headache
    • Nausea
    • Abdominal pain
    • Diarrhea
    • Flatulence
  • Serious side effects such as Clostridium difficile-associated diarrhea and hypomagnesemia may occur but are rare.

Experience the efficacy and reliability of AIT Pharmaceuticals Division’s Rabeprazole Sodium Tablets in the management of acid-related disorders. For more information, please contact us.

 

Reviews

There are no reviews yet.

Be the first to review “Rabeprazole sodium”

Your email address will not be published. Required fields are marked *